vs

Side-by-side financial comparison of SIMMONS FIRST NATIONAL CORP (SFNC) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

Tilray Brands, Inc. is the larger business by last-quarter revenue ($217.5M vs $197.3M, roughly 1.1× SIMMONS FIRST NATIONAL CORP). On growth, SIMMONS FIRST NATIONAL CORP posted the faster year-over-year revenue change (19.6% vs 3.1%). Over the past eight quarters, Tilray Brands, Inc.'s revenue compounded faster (7.5% CAGR vs 0.6%).

Simmons Bank is a bank with operations in Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas. It is the primary subsidiary of Simmons First National Corporation, a bank holding company.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

SFNC vs TLRY — Head-to-Head

Bigger by revenue
TLRY
TLRY
1.1× larger
TLRY
$217.5M
$197.3M
SFNC
Growing faster (revenue YoY)
SFNC
SFNC
+16.5% gap
SFNC
19.6%
3.1%
TLRY
Faster 2-yr revenue CAGR
TLRY
TLRY
Annualised
TLRY
7.5%
0.6%
SFNC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
SFNC
SFNC
TLRY
TLRY
Revenue
$197.3M
$217.5M
Net Profit
$-44.9M
Gross Margin
26.4%
Operating Margin
-10.2%
Net Margin
-20.7%
Revenue YoY
19.6%
3.1%
Net Profit YoY
47.4%
EPS (diluted)
$0.36
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SFNC
SFNC
TLRY
TLRY
Q4 25
$197.3M
$217.5M
Q3 25
$186.7M
$209.5M
Q2 25
$214.2M
$224.5M
Q1 25
$209.6M
$185.8M
Q4 24
$208.5M
$210.9M
Q3 24
$174.8M
$200.0M
Q2 24
$197.2M
$229.9M
Q1 24
$195.1M
$188.3M
Net Profit
SFNC
SFNC
TLRY
TLRY
Q4 25
$-44.9M
Q3 25
$-562.8M
$-322.0K
Q2 25
$54.8M
$-1.3B
Q1 25
$32.4M
$-789.4M
Q4 24
$-85.3M
Q3 24
$24.7M
$-39.2M
Q2 24
$40.8M
$-31.7M
Q1 24
$38.9M
$-92.7M
Gross Margin
SFNC
SFNC
TLRY
TLRY
Q4 25
26.4%
Q3 25
27.4%
Q2 25
30.1%
Q1 25
28.0%
Q4 24
29.0%
Q3 24
29.8%
Q2 24
35.8%
Q1 24
26.2%
Operating Margin
SFNC
SFNC
TLRY
TLRY
Q4 25
-10.2%
Q3 25
1.0%
Q2 25
-643.1%
Q1 25
-409.0%
Q4 24
-20.0%
Q3 24
-18.3%
Q2 24
-7.2%
Q1 24
-43.6%
Net Margin
SFNC
SFNC
TLRY
TLRY
Q4 25
-20.7%
Q3 25
-301.5%
-0.2%
Q2 25
25.6%
-566.9%
Q1 25
15.5%
-424.9%
Q4 24
-40.5%
Q3 24
14.1%
-19.6%
Q2 24
20.7%
-13.8%
Q1 24
19.9%
-49.2%
EPS (diluted)
SFNC
SFNC
TLRY
TLRY
Q4 25
$0.36
$-0.41
Q3 25
$-4.00
$0.00
Q2 25
$0.43
$7.26
Q1 25
$0.26
$-8.69
Q4 24
$0.38
$-0.99
Q3 24
$0.20
$-0.04
Q2 24
$0.32
$-0.04
Q1 24
$0.31
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SFNC
SFNC
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$291.6M
Total DebtLower is stronger
$620.0M
Stockholders' EquityBook value
$3.4B
$1.6B
Total Assets
$24.5B
$2.1B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SFNC
SFNC
TLRY
TLRY
Q4 25
$291.6M
Q3 25
$264.8M
Q2 25
$256.4M
Q1 25
Q4 24
$252.2M
Q3 24
$280.1M
Q2 24
$260.5M
Q1 24
$225.9M
Total Debt
SFNC
SFNC
TLRY
TLRY
Q4 25
$620.0M
Q3 25
$667.8M
Q2 25
$1.0B
Q1 25
$1.3B
Q4 24
$1.1B
Q3 24
$1.4B
Q2 24
$1.7B
Q1 24
$1.2B
Stockholders' Equity
SFNC
SFNC
TLRY
TLRY
Q4 25
$3.4B
$1.6B
Q3 25
$3.4B
$1.5B
Q2 25
$3.5B
$1.5B
Q1 25
$3.5B
$2.7B
Q4 24
$3.5B
$3.5B
Q3 24
$3.5B
$3.5B
Q2 24
$3.5B
$3.4B
Q1 24
$3.4B
$3.4B
Total Assets
SFNC
SFNC
TLRY
TLRY
Q4 25
$24.5B
$2.1B
Q3 25
$24.2B
$2.1B
Q2 25
$26.7B
$2.1B
Q1 25
$26.8B
Q4 24
$26.9B
$4.2B
Q3 24
$27.3B
$4.3B
Q2 24
$27.4B
$4.2B
Q1 24
$27.4B
$4.2B
Debt / Equity
SFNC
SFNC
TLRY
TLRY
Q4 25
0.18×
Q3 25
0.20×
Q2 25
0.28×
Q1 25
0.35×
Q4 24
0.32×
Q3 24
0.40×
Q2 24
0.50×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SFNC
SFNC
TLRY
TLRY
Operating Cash FlowLast quarter
$449.5M
$-8.5M
Free Cash FlowOCF − Capex
$411.4M
FCF MarginFCF / Revenue
208.5%
Capex IntensityCapex / Revenue
19.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$717.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SFNC
SFNC
TLRY
TLRY
Q4 25
$449.5M
$-8.5M
Q3 25
$223.4M
$-1.3M
Q2 25
$77.6M
$-12.8M
Q1 25
$32.8M
$-5.8M
Q4 24
$425.9M
$-40.7M
Q3 24
$199.4M
$-35.3M
Q2 24
$86.1M
$30.7M
Q1 24
$57.6M
$-15.4M
Free Cash Flow
SFNC
SFNC
TLRY
TLRY
Q4 25
$411.4M
Q3 25
$216.7M
Q2 25
$66.3M
$-19.1M
Q1 25
$22.6M
$-20.2M
Q4 24
$380.4M
$-46.2M
Q3 24
$187.7M
$-42.0M
Q2 24
$72.7M
$21.0M
Q1 24
$47.7M
$-24.9M
FCF Margin
SFNC
SFNC
TLRY
TLRY
Q4 25
208.5%
Q3 25
116.1%
Q2 25
31.0%
-8.5%
Q1 25
10.8%
-10.9%
Q4 24
182.5%
-21.9%
Q3 24
107.4%
-21.0%
Q2 24
36.9%
9.1%
Q1 24
24.5%
-13.2%
Capex Intensity
SFNC
SFNC
TLRY
TLRY
Q4 25
19.3%
Q3 25
3.6%
Q2 25
5.3%
2.8%
Q1 25
4.8%
7.8%
Q4 24
21.8%
2.6%
Q3 24
6.7%
3.4%
Q2 24
6.8%
4.2%
Q1 24
5.0%
5.1%
Cash Conversion
SFNC
SFNC
TLRY
TLRY
Q4 25
Q3 25
Q2 25
1.42×
Q1 25
1.01×
Q4 24
Q3 24
8.06×
Q2 24
2.11×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SFNC
SFNC

Segment breakdown not available.

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons